Kaplan-Meier probability of disease-free survival after double-unit UCBT according to disease status. Patients with acute leukemia in remission or with chronic myelogenous leukemia had a significantly better survival than those patients with acute leukemia who were given transplants while in relapse, or secondary AML patients with recurrent myelodysplasia.